Significant Ownership of Camber Capital Management LP

Signature - Title
/s/ Sean George - Chief Financial Officer
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Camber Capital Management LP.

Notify me when Camber Capital Management LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Camber Capital Management LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PTCT PTC THERAPEUTICS, INC. Common Stock $0.001 par value per share 4.2% $136,800,000 3,200,000 Camber Capital Management LP 31 Dec 2024
INGN Inogen Inc Common Stock, $0.001 par value 3.7% $6,912,750 975,000 Camber Capital Management LP 31 Mar 2025
MYGN MYRIAD GENETICS INC Common Stock, par value $0.01 per share 3.4% $26,195,000 3,100,000 Camber Capital Management LP 31 Dec 2024
BKD Brookdale Senior Living Inc. Common Stock, $0.01 par value 2.7% $39,375,000 -$68,786,708 6,250,000 -64% Camber Capital Management LP 31 Mar 2025
OSUR ORASURE TECHNOLOGIES INC Common Stock, $0.000001 par value 1.2% $3,033,000 900,000 Camber Capital Management LP 31 Mar 2025
SLDB Solid Biosciences Inc. Common Stock,$0.001 par value per share 0% $0 0 Camber Capital Management LP 31 Dec 2024
ZIMV ZimVie Inc. Common Stock, par value $0.01 per share 0% $0 -$30,160,000 0 -100% Camber Capital Management LP 21 Jul 2025
PBYI PUMA BIOTECHNOLOGY, INC. Common Stock, par value $0.0001 per share 0% $0 0 Camber Capital Management LP 31 Dec 2024

Schedules 13D/G Reported by Camber Capital Management LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.